Oct 19 (Reuters) – Swedish medical equipment maker Getinge (GETIb.ST) cut its 2022 sales outlook for the second time this year on Wednesday, citing uncertainty around supply chain disruptions and China’s zero-COVID policy.
The company forecast a 3% to 6% decline in its full-year organic sales. It had previously guided for sales in line with last year.
It also said elective surgeries at hospitals had not yet recovered to pre-pandemic levels, leading to lower order intake and sales in the third quarter.
Register now for FREE unlimited access to Reuters.com
Reporting by Marta Frackowiak in Gdansk; editing by Milla Nissi
Our Standards: The Thomson Reuters Trust Principles.
